126 related articles for article (PubMed ID: 32173047)
1. Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequity.
Awad E; Paladugu R; Jones N; Pierce JY; Scalici J; Hamilton CA; Darcy KM; Maxwell GL; Rocconi RP
Gynecol Oncol; 2020 Jun; 157(3):729-732. PubMed ID: 32173047
[TBL] [Abstract][Full Text] [Related]
2. Minority participation in Gynecologic Oncology Group (GOG) Studies.
Scalici J; Finan MA; Black J; Harmon MD; Nicolson W; Lankes HA; Brady WE; Rocconi RP
Gynecol Oncol; 2015 Aug; 138(2):441-4. PubMed ID: 26013697
[TBL] [Abstract][Full Text] [Related]
3. Underrepresentation of racial and ethnic minority groups in gynecologic oncology: An analysis of over 250 trials.
Richardson MT; Barry D; Steinberg JR; Thirunavu V; Strom DE; Holder K; Zhang N; Turner BE; Magnani CJ; Weeks BT; Young AMP; Lu CF; Wolgemuth TR; Laasiri N; Squires NA; Anderson JN; Karlan BY; Chan JK; Kapp DS; Roque DR; Salani R
Gynecol Oncol; 2024 Feb; 181():1-7. PubMed ID: 38096673
[TBL] [Abstract][Full Text] [Related]
4. Enrollment of Individuals From Racial and Ethnic Minority Groups in Gynecologic Cancer Precision Oncology Trials.
Mattei LH; Robb L; Banning K; Polan RM; Cote ML
Obstet Gynecol; 2022 Oct; 140(4):654-661. PubMed ID: 36075065
[TBL] [Abstract][Full Text] [Related]
5. Not immune to inequity: minority under-representation in immunotherapy trials for breast and gynecologic cancers.
Grette KV; White AL; Awad EK; Scalici JM; Young-Pierce J; Rocconi RP; Jones NL
Int J Gynecol Cancer; 2021 Nov; 31(11):1403-1407. PubMed ID: 34088749
[TBL] [Abstract][Full Text] [Related]
6. Demographic reporting and language exclusion in gynecologic oncology clinical trials.
Lee SS; Dinicu AI; Arthurs L; Shields D; Pothuri B; Lightfoot MDS
Am J Obstet Gynecol; 2024 Jan; 230(1):73.e1-73.e14. PubMed ID: 37751830
[TBL] [Abstract][Full Text] [Related]
7. Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies.
Aldrighetti CM; Niemierko A; Van Allen E; Willers H; Kamran SC
JAMA Netw Open; 2021 Nov; 4(11):e2133205. PubMed ID: 34748007
[TBL] [Abstract][Full Text] [Related]
8. Diversity and transparency in gynecologic oncology clinical trials.
Montes de Oca MK; Howell EP; Spinosa D; Knochenhauer H; Peipert BJ; Severson E; Ramkissoon S; Akinyemiju TF; Previs RA
Cancer Causes Control; 2023 Feb; 34(2):133-140. PubMed ID: 36284031
[TBL] [Abstract][Full Text] [Related]
9. Participation of Patients With Limited English Proficiency in Gynecologic Oncology Clinical Trials.
Jorge S; Masshoor S; Gray HJ; Swisher EM; Doll KM
J Natl Compr Canc Netw; 2023 Jan; 21(1):27-32.e2. PubMed ID: 36634612
[TBL] [Abstract][Full Text] [Related]
10. Minority Enrollment to Clinical Trials: Road to Increased Access.
Vose J
Oncology (Williston Park); 2021 Mar; 35(3):107. PubMed ID: 33818053
[TBL] [Abstract][Full Text] [Related]
11. Racial and ethnic enrollment disparities in clinical trials of poly(ADP-ribose) polymerase inhibitors for gynecologic cancers.
Wagar MK; Mojdehbakhsh RP; Godecker A; Rice LW; Barroilhet L
Gynecol Oncol; 2022 Apr; 165(1):49-52. PubMed ID: 35144798
[TBL] [Abstract][Full Text] [Related]
12. Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review.
Tahhan AS; Vaduganathan M; Greene SJ; Alrohaibani A; Raad M; Gafeer M; Mehran R; Fonarow GC; Douglas PS; Bhatt DL; Butler J
JAMA Cardiol; 2020 Jun; 5(6):714-722. PubMed ID: 32211813
[TBL] [Abstract][Full Text] [Related]
13. Enrollment of Racial and Ethnic Minoritized Groups in Gynecologic Oncology Clinical Trials: A Review of the Scope of the Problem, Contributing Factors, and Strategies to Improve Inclusion.
Barry D; Steinberg JR; Towner M; Barber EL; Simon MA; Roque DR
Clin Obstet Gynecol; 2023 Mar; 66(1):22-35. PubMed ID: 36657045
[TBL] [Abstract][Full Text] [Related]
14. Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002.
Djomand G; Katzman J; di Tommaso D; Hudgens MG; Counts GW; Koblin BA; Sullivan PS
Public Health Rep; 2005; 120(5):543-8. PubMed ID: 16224987
[TBL] [Abstract][Full Text] [Related]
15. Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participation.
Nooka AK; Behera M; Lonial S; Dixon MD; Ramalingam SS; Pentz RD
Cancer; 2016 Oct; 122(20):3207-3214. PubMed ID: 27404488
[TBL] [Abstract][Full Text] [Related]
16. Enrollment in clinical trials according to patients race: experience from the VA Cooperative Studies Program (1975-2000).
Oddone EZ; Olsen MK; Lindquist JH; Orr M; Horner R; Reda D; Lavori P; Johnson G; Collins J; Feussner JR
Control Clin Trials; 2004 Aug; 25(4):378-87. PubMed ID: 15296812
[TBL] [Abstract][Full Text] [Related]
17. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
[TBL] [Abstract][Full Text] [Related]
18. What's in it for me?: A value assessment of gynecologic cancer clinical trials for Black women.
Oluloro A; Temkin SM; Jackson J; Swisher EM; Sage L; Doll K
Gynecol Oncol; 2023 May; 172():29-35. PubMed ID: 36931101
[TBL] [Abstract][Full Text] [Related]
19. Minority Representation in Migraine Treatment Trials.
Robbins NM; Bernat JL
Headache; 2017 Mar; 57(3):525-533. PubMed ID: 28127754
[TBL] [Abstract][Full Text] [Related]
20. Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.
Wissing MD; Kluetz PG; Ning YM; Bull J; Merenda C; Murgo AJ; Pazdur R
Cancer; 2014 Oct; 120(19):3025-32. PubMed ID: 24965506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
